LADENBURG THALMANN FINANCIAL SERVICES INC. - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 71 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2019$6,0000.0%7850.0%0.00%
Q3 2019$6,000
+20.0%
7850.0%0.00%
Q2 2019$5,000
-16.7%
7850.0%0.00%
Q1 2019$6,0000.0%7850.0%0.00%
Q4 2018$6,000
-25.0%
7850.0%0.00%
Q3 2018$8,0007850.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,291,151$8,844,0003.78%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 335,279$2,297,0002.84%
Abingworth LLP 240,500$1,638,0000.63%
Nantahala Capital Management 2,852,260$19,538,0000.60%
RITHOLTZ WEALTH MANAGEMENT 290,534$1,990,0000.34%
Orbimed Advisors 2,165,524$14,834,0000.23%
Rock Springs Capital Management LP 800,000$5,480,0000.20%
SPHERA FUNDS MANAGEMENT LTD. 187,206$1,282,0000.18%
Leap Investments LP 16,600$114,0000.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 500,046$3,425,0000.12%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders